中国科技论文统计源期刊 中文核心期刊  
美国《化学文摘》《国际药学文摘》
《乌利希期刊指南》
WHO《西太平洋地区医学索引》来源期刊  
日本科学技术振兴机构数据库(JST)
第七届湖北十大名刊提名奖  
医药导报, 2017, 36(2): 175-178
doi: 10.3870/j.issn.1004-0781.2017.02.014
盐酸右美托咪定对腹腔镜结直肠癌根治术患者麻醉苏醒质量的影响
叶刚, 朱贤林, 吴述轩, 刘川鄂, 覃斌

摘要: 目的观察盐酸右美托咪啶对腹腔镜结直肠癌根治术患者麻醉苏醒质量的影响。方法选取择期行腹腔镜结直肠癌根治术的全麻患者60例,按随机数字表法分为对照组和治疗组,每组30例。治疗组于麻醉诱导前20 min静脉输注盐酸右美托咪定0.8 mg·kg-1,麻醉诱导完成后持续静脉输注盐酸右美托咪定0.5 μg·kg-1·h-1至术毕,对照组静脉输注等容量0.9%氯化钠注射液。观察两组患者苏醒拔管时间及术后呛咳、躁动发生情况。结果对照组和治疗组患者术后自主呼吸恢复时间分别为(14.46±3.46)与(13.83±3.15) min,睁眼时间分别为(19.74±3.44)与(18.62±3.53) min,拔管时间分别为(24.83±4.63)与(22.17±3.26) min,均差异无统计学意义(P>0.05);对照组和治疗组患者呛咳发生率分别为46.67%和13.33%,躁动发生率分别为40.0%和13.33%,差异有统计学意义(P<0.01)。结论盐酸右美托咪啶能改善腹腔镜结直肠癌根治术患者麻醉苏醒质量。
关键词: 右美托咪定,盐酸 ; 手术,腹腔镜 ; 结直肠癌根治术 ; 苏醒质量

Abstract:

腹腔镜手术作为一种新型微创手术方法,具有手术创伤小、术后恢复快等优点,被越来越多的外科医生及患者认可。由于大多数结直肠癌患者本身生理条件较差,加上二氧化碳(CO2)气腹和体位变化能够对呼吸循环系统产生影响[1],因而增加全麻苏醒期的风险。盐酸右美托咪定(dexmedetomidine,Dex)是一种新型高选择性α2肾上腺素能受体激动药,能够有效调节大脑皮质的觉醒反应,具有镇静、镇痛、抗焦虑、抗交感、呼吸抑制轻和易唤醒等优点[2-3],广泛应用于临床。虽然有文献报道盐酸右美托咪定有助于维持全麻和手术期间患者血流动力学稳定,并有效改善老年患者术后苏醒期躁动[4],但针对腹腔镜下行结直肠癌根治术患者的资料仍然不全。2013年10月—2014年10月,笔者观察了盐酸右美托咪定对腹腔镜结直肠癌根治术患者麻醉苏醒质量的影响,旨在为降低全麻术后苏醒期并发症寻找一种更加有效的办法。

1 资料与方法
1.1 临床资料

选取我院择期行腹腔镜结直肠癌根治术的全麻患者60例,年龄42~65岁,男34例,女26例,美国麻醉医师协会(American Society of Anesthesiologists,ASA)分级Ⅰ或Ⅱ级。所有患者术前无严重心脑血管疾病,肝、肾功能正常,无糖尿病、甲状腺功能亢进及凝血功能障碍。排除窦性心动过缓、左束支传导阻滞、麻醉药物过敏,以及严重呼吸疾病史患者。试验经本院医院伦理委员会批准,并与患者签署知情同意书。按随机数字表法将其随机分为对照组和治疗组,每组30例。采用信封装填代码进行分配隐藏。术中若因手术操作不顺导致大量出血或病情危重,病例将被剔除。两组患者年龄、性别比例、体质量等一般资料比较,差异无统计学意义(P>0.05),具有可比性。见表1。

表1 两组患者一般资料比较x¯±s
组别 例数 性别(男/女) 年龄/岁 体质量/kg 体重指数/[kg·(m2)-1] ASA分级(Ⅰ/Ⅱ)/例
对照组 30 19/11 56.7±5.6 57.3±13.5 22.86±3.14 16/14
治疗组 30 17/13 58.2±5.3 59.7±14.2 23.24±3.76 18/12
t/χ2 0.364 0.047 -1.535 0.923 2.034
P 0.463 0.852 0.214 0.376 0.105

表1 两组患者一般资料比较x¯±s

1.2 麻醉方法

入手术室前30 min肌内注射阿托品0.5 mg,苯巴比妥钠0.1 g,作为术前用药。患者入手术室后常规监测心电图(ECG)、无创血压(BP)和脉搏氧饱和度(SpO2),并采用脑电双频谱指数(bispectral index,BIS)监测术中麻醉深度。常规面罩吸氧。治疗组于麻醉诱导前20 min静脉滴注盐酸右美托咪定注射液(江苏恒瑞医药股份有限公司,批准文号:国药准字H20090248,规格:200 μg∶2 mL,0.9%氯化钠注射液稀释成4 μg·mL-1)0.8 μg·kg-1,对照组静脉滴注等容量0.9%氯化钠注射液。两组患者均采用咪达唑仑0.05 mg·kg-1、舒芬太尼0.4 μg·kg-1、丙泊酚1.5 mg·kg-1、罗库溴铵0.5 mg·kg-1,静脉注射快速诱导,气管插管后连接麻醉机行机械通气,通气参数为:潮气量( VT) 8~10 mL·kg-1,呼吸频率12 次·min-1,吸入氧浓度(FiO2) 40%~60% 以维持PETCO2在4.655~5.985 kPa,SpO2≥95%。持续靶控输注丙泊酚4 μg·kg-1·min-1,瑞芬太尼0.3~0.8 μg·kg-1·min-1,维库溴铵1.0~1.5 μg·kg-1·min-1维持麻醉。治疗组在麻醉诱导完成后持续静脉输注盐酸右美托咪定0.5 μg·kg-1·h-1,对照组静脉输注等容量0.9%氯化钠注射液,两组患者术中麻醉深度均维持BIS值在40~60,手术结束前10 min停用所有麻醉药。手术完成后将患者送至麻醉恢复室,待患者自主呼吸恢复、意识清醒、肌张力恢复良好后拔管。

1.3 观察指标及评价标准

1.3.1 观察指标 观察两组患者术后自主呼吸恢复时间、睁眼时间、拔管时间及呛咳和躁动发生率。记录麻醉诱导前(t0)、气管插管完成后即刻(t1)、气管导管拔除即刻(t2)、气管导管拔除后拔管后10 min(t3)的心率(HR)、平均动脉血压(MAP)、SpO2

1.3.2 评价标准 ①呛咳的判定采用四分表法进行评分,1分:无呛咳;2分:轻度呛咳(1或2次);3分:中度呛咳(3或4次);4分:重度呛咳(≥5次);1~2分考虑为能耐受气管导管,被认定为无呛咳,3~4分考虑为不能耐受气管导管,被认定为有呛咳。②躁动评分按照患者的临床症状分5个级别, 1 分:患者睡眠平静,对外界的刺激迟钝无反应;2 分:患者清醒、对刺激有一定反应,但保持平静;3 分:患者清醒、能对刺激作出准确反应,且情绪激动、易怒;4 分:患者存在无法控制的哭喊、难以安慰;5 分:患者狂躁不安、难以约束并存在有迷惑、谵妄。1~2 分无躁动;3 分轻、中度躁动;4~5 分重度躁动。躁动率的计算只计入4~5分患者。

1.4 安全监测及应对方案

试验前备好血管活性药物和阿托品,试验期间患者若出现严重低血压、窦性心动过缓、传导阻滞等并发症时,立即停止输注盐酸右美托咪定,分析原因并给予对症处理。该患者将退出试验,其数据不纳入统计分析。

1.5 统计学方法

采用SPSS17.0版软件对数据进行统计分析。计量资料采用均数±标准差( x ̅ ±s)表示,组间均数比较采用t检验;计数资料均采用百分率(%)表示,组间比较采用χ2检验;不同时间点重复测量数据采用重复测量方差分析。以P<0.05 为差异有统计学意义。

2 结果
2.1 两组生命体征变化情况

所有患者在麻醉诱导和苏醒期间生命体征维持相对平稳。但对照组患者在气管插管和气管拔管期间的HR、MAP有一定的波动。与基础值(t0)比较,对照组患者HR、MAP在t1和t2两个时间点明显升高,差异有统计学意义(P<0.05);治疗组患者HR、MAP在各观测时间点均没有明显变化,差异无统计学意义(均P>0.05);组间比较发现,两组患者HR、MAP在t0差异无统计学意义(P>0.05);与对照组比较,治疗组患者HR在t1和t2两个时间点明显降低,而MAP在t1时刻有所升高,t2时刻有所下降,均差异有统计学意义(均P<0.05);两组患者SpO2在各观测时间点均差异无统计学意义(P>0.05)。见表2。

表2 两组患者不同时间点HR、MAP和SpO2的变化x¯±s,n= 30
组别与时间 HR/(次·min-1) MAP/mmHg SpO2/% 组别与时间 HR/(次·min-1) MAP/mmHg SpO2/%
对照组 治疗组
t0 74.5±11.5 91.7±11.6 98.3±1.5 t0 76.7±10.6 93.4±12.6 98.7±1.6
t1 88.2±12.4*1 78.4±10.5*1 99.4±1.2 t1 70.4±10.7*2 89.6±11.6*2 99.6±1.1
t2 91.4±13.3*1 112.5±13.4*1 98.8±1.1 t2 78.5±11.5*3 96.5±12.5*2 99.7±0.9
t3 74.3±10.3 89.5±11.3 97.4±1.4 t3 63.8±9.8*1 92.6±10.5 98.5±1.2
F 14.578 18.763 0.887 F 6.436 2.537 1.564
P <0.01 <0.01 0.477 P 0.021 0.134 0.383

与本组t0比较,*1P<0.05;与对照组同一时间比较,t=7.753,5.371,2.453,*2P<0.01;t=3.146,*3P<0.05

表2 两组患者不同时间点HR、MAP和SpO2的变化x¯±s,n= 30

2.2 苏醒时间及并发症发生率比较

两组患者自主呼吸恢复时间、睁眼时间、拔管时间均差异无统计学意义(P>0.05);与对照组比较,治疗组患者呛咳发生率和躁动发生率明显下降,差异有统计学意义(P<0.01)。见表3 。

表3 两组患者术后苏醒时间及并发症发生率比较 x¯±s,n= 30
组别 自主呼吸恢复时间 睁眼时间
min
拔管时间 呛咳发生率 躁动发生率
%
对照组 14.46±3.46 19.74±3.44 24.83±4.63 46.67 40.00
治疗组 13.83±3.15 18.62±3.53 22.17±3.26 13.33 13.33
t/χ2 0.364 0.487 0.182 18.263 12.436
P 0.536 0.425 0.178 <0.01 <0.01

表3 两组患者术后苏醒时间及并发症发生率比较 x¯±s,n= 30

3 讨论

由于麻醉药、肌松药的残余作用,全麻患者保护性反射没有完全恢复,加上手术创伤及机体内外环境的改变,麻醉苏醒期极易发生血流动力学不稳定、苏醒延迟、呛咳及兴奋性躁动等各种并发症,从而导致意外伤害,甚至危及患者生命安全。考虑到盐酸右美托咪定没有明显的呼吸抑制效应[5],以及良好的镇痛及中枢性抗交感效应[6],其作为辅助全麻药物复合应用于腹腔镜结直肠癌根治术患者,将有利于降低机体的应激反应,从而有效改善全麻苏醒质量。

强烈的应激能导致交感神经兴奋及分泌大量儿茶酚胺,引起应激性高血压,甚至心肌损伤和致命性心律失常[7]。气管插管和气管拔管是麻醉手术过程中两个不可避免的应激环节,如果处理不当,将引起患者呛咳及循环剧烈波动,增加心脑血管意外。本研究结果发现,治疗组患者的心率和血压在t1和t2均明显低于对照组,更接近于基础水平。本研究结果表明,右美托咪定有助于降低机体应激反应和维持血流动力学稳定,其作用机制与激动脑和脊髓α2肾上腺素受体、降低交感神经的活性、减少儿茶酚胺释放有关[8]。另外,治疗组患者苏醒期呛咳发生率明显低于对照组,与前期研究结果一致[9]

苏醒期躁动是围术期常见并发症,表现一过性意识障碍和行为异常,发生率18%~80%,严重时还可导致记忆能力、思维定向能力、社会交往能力减退,甚者出现痴呆[10]。引起术后躁动的因素众多,包括年龄、药物残留作用、疼痛、代谢紊乱及中枢神经系统并发症等。前期究表明,α2肾上腺素能受体激动药和阿片类药物均能够有效降低术后躁动发生率[11]。在本研究中,与对照组比较,治疗组患者苏醒期躁动发生率下降显著,进一步支持了上述观点。理论上,由于盐酸右美托咪定的消除半衰期约为2 h,且会随着给药时间的延长而增加,因而可能会导致苏醒延迟。然而,在本研究中,盐酸右美托咪定并没有导致患者苏醒延迟,两组患者的自主呼吸恢复时间、睁眼时间和拔管时间差异均无统计学意义。这可能归因于盐酸右美托咪定与其他镇静催眠药物的作用机制不同,在一定剂量范围内,盐酸右美托咪定能够产生自然非动眼睡眠,机体的唤醒系统功能仍然存在有关[12-13]

综上所述,盐酸右美托咪定用于腹腔镜结直肠癌根治术患者,不仅有助于稳定血流动力学指标,预防苏醒期呛咳和躁动,而且不增加苏醒延迟的风险,具有较高的安全性,值得临床推广使用。

The authors have declared that no competing interests exist.

参考文献

[1] JOSHI G P.Complications of laparoscopy[J].Anesthesiol Clin North Am, 2001,19(1):89-105.
[本文引用:1]
[2] ALKIRE M T, MCREYNOLDS J R, HAHN E L, et al.Thalamic microinjection of nicotinereverses sevoflurane-induced loss of righting reflex in the rat[J]. Anesthesiology, 2007,107(2):264-272.
Abstract Neuronal nicotinic acetylcholine receptors are both potently inhibited by anesthetics and densely expressed in the thalamus. Brain imaging shows that thalamic activity suppression accompanies anesthetic-induced unconsciousness. Therefore, anesthetic-induced unconsciousness may involve direct antagonism of thalamic nicotinic receptors. The authors test this by separately attempting to block or enhance anesthetic-induced loss of righting in rats using intrathalamic microinjections of nicotine or its antagonist. Rats were implanted with a cannula aimed at the thalamus or control locations. A week later, loss of righting was induced using sevoflurane (1.4 +/- 0.2%). A dose-parameter study (n = 35) first identified an optimal intrathalamic nicotine dose associated with arousal. Subsequently, this dose was used to pinpoint the thalamic site mediating the arousal response (n = 107). Finally, sevoflurane righting dose and response specificity were assessed after blocking nicotinic channels with intrathalamic mecamylamine pretreatment (n = 8) before nicotine challenge. Nicotine (150 microg/0.5 microl over 1 min) was the optimal arousal dose, because lower doses (75 microg) were ineffective and higher doses (300 microg) often caused seizures. Nicotine temporarily restored righting and mobility in animals when microinjections involved the central medial thalamus (P < 0.0001, chi-square). Righting occurred despite continued sevoflurane administration. Intrathalamic mecamylamine pretreatment did not lower the sevoflurane dose associated with loss of righting, but prevented the nicotine arousal response. The reversal of unconsciousness found here with intrathalamic microinfusion of nicotine suggests that suppression of the midline thalamic cholinergic arousal system is part of the mechanism by which anesthetics produce unconsciousness.
DOI:10.1097/01.anes.0000270741.33766.24      PMID:17667571      URL    
[本文引用:1]
[3] HUUPPONEN E, MAKSIMOW A, LAPINLAMPI P, et al.Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep[J]. Acta Anaesthesiol Scand, 2008, 52(2):289-294.
Background: Dexmedetomidine, a selective α-adrenoceptor agonist, induces a unique, sleep-like state of sedation. The objective of the present work was to study human electroencephalogram (EEG) sleep spindles during dexmedetomidine sedation and compare them with spindles during normal physiological sleep, to test the hypothesis that dexmedetomidine exerts its effects via normal sleep-promoting pathways. Methods: EEG was continuously recorded from a bipolar frontopolar–laterofrontal derivation with Entropy Module (GE Healthcare) during light and deep dexmedetomidine sedation (target-controlled infusions set at 0.5 and 3.265ng/ml) in 11 healthy subjects, and during physiological sleep in 10 healthy control subjects. Sleep spindles were visually scored and quantitatively analyzed for density, duration, amplitude (band-pass filtering) and frequency content (matching pursuit approach), and compared between the two groups. Results: In visual analysis, EEG activity during dexmedetomidine sedation was similar to physiological stage 2 (S2) sleep with slight to moderate amount of slow-wave activity and abundant sleep spindle activity. In quantitative EEG analyses, sleep spindles were similar during dexmedetomidine sedation and normal sleep. No statistically significant differences were found in spindle density, amplitude or frequency content, but the spindles during dexmedetomidine sedation had longer duration (mean 1.1165s, SD 0.1465s) than spindles in normal sleep (mean 0.8865s, SD 0.1465s; =0.0014). Conclusions: Analysis of sleep spindles shows that dexmedetomidine produces a state closely resembling physiological S2 sleep in humans, which gives further support to earlier experimental evidence for activation of normal non-rapid eye movement sleep-promoting pathways by this sedative agent.
DOI:10.1111/j.1399-6576.2007.01537.x      PMID:18005372      URL    
[本文引用:1]
[4] 刘铁军, 张树波, 韩晓亮, .右美托咪定对老年患者腹腔镜卵巢癌根治术后苏醒与认知功能的影响[J].浙江临床医学, 2015, 17(3):346-348.
目的探讨右美托咪定对老年患者腹腔镜卵巢癌根治术后苏醒与认知功能的影响。方法选取2010年10月至2013年12月行腹腔镜卵巢癌根治术的老年患者134例,采用随机数字表法分为两组,67例患者行右美托咪定泵注为观察组,67例患者行生理盐水泵注为对照组,采用简易精神状态量表(MMSE)评定患者的认知功能,比较两组患者相关临床指标的改变情况、术后苏醒时间、苏醒期的躁动情况、认知功能状况、不良反应情况。结果观察组患者心率、平均动脉压、中心静脉压、心输出量、肾上腺素、去甲肾上腺素变化平稳,未见明显波动。对照组患者心率、平均动脉压、心输出量、肾上腺素、去甲肾上腺素在T1时均显著升高。对照组患者中心静脉压在T1时显著降低。观察组患者在T1、T2、T3、T4时心率、平均动脉压、心输出量、肾上腺素、去甲肾上腺素均明显低于对照组。观察组患者在T1、T2、T3、T4时中心静脉压明显高于对照组。观察组患者躁动发生率、躁动评分、不良反应发生率均明显低于对照组,观察组患者躁动评级明显好于对照组,差异均有统计学意义(P〈0.05)。两组患者认知功能评分在Tb时均显著降低,在Td时均恢复正常。结论右美托咪定有助于稳定血流动力学指标,预防苏醒期躁动,但可能造成苏醒延迟,对老年患者腹腔镜卵巢癌根治术后认知功能无明显影响,不良反应少,具有较高的安全性,值得临床推广使用。
URL    
[本文引用:1]
[5] FAN Q, HU C, YE M, et al.Dexmedetomidine for tracheal extubation in deeply anesthetized adult patients after otologic surgery: acomparison with remifentanil[J]. BMC Anesthesiol, 2015, 15:106.
ABSTRACT Background: Remifentanil and dexmedetomidine are well known to suppress airway reflexes during airway procedures. Smooth tracheal extubation is important after otologic surgery. The purpose of this study is to compare the effectiveness of dexmedetomidine or remifentanil infusion for producing smooth tracheal extubation in deeply anesthetized patients after otologic surgery. Methods: Seventy-four ASA I-II adult patients (18-60 years old) scheduled for elective otologic surgery were randomly assigned to one of three groups: sevoflurane-remifentanil (Group SR, n = 25), sevoflurane-dexmedetomidine (0.5 渭g/kg) (Group SD5, n = 24), or sevoflurane-dexmedetomidine (0.7 渭g/kg) (Group SD7, n = 25). Remifentanil or dexmedetomidine were administered for 10 min at the end of surgery. The primary outcome was the rate of smooth extubation. Respiratory pattern, airway obstruction, hemodynamic and respiratory profiles, time to awake, rescue analgesics in the post-anesthesia care unit (PACU), and postoperative nausea and vomiting (PONV) were also recorded. Results: The rate of smooth tracheal extubation as defined 1 min post-extubation was the same for Groups SR and SD7 (P > 0.05), but the rate of smooth extubation was lower for Group SD5 than for the other two groups (p 0.05), but the mean arterial pressure and heart rate were higher in Group SR at 10 and 15 min after extubation (p 0.05). The need for rescue analgesic in the PACU was more common in Group SR than in both dexmedetomidine groups (P < 0.01). Compared to Group SR, both dexmedetomidine groups had less PONV on postoperative day 1 (p < 0.05). Conclusion: Combined with 1 MAC sevoflurane, dexmedetomidine 0.7 ug/kg and remifentanil provided similar rates for smooth tracheal extubation in spontaneously breathing, anesthetized adults. Dexmedetomidine exhibited opioid-sparing effects postoperatively and was associated with less PONV than remifentanil.
DOI:10.1186/s12871-015-0088-7      PMID:4511974      URL    
[本文引用:1]
[6] NEGI S, SEN I, ARYA V, et al.Dexmedetomidine versus fentanyl as co-adjuvants of balanced anaesthesia technique in renal transplant recipients[J].Middle East J Anaesthesiol, 2014, 22(6):549-557.
Ideal anesthetic technique for renal allograft recipients should provide hemodynamic stability, optimum graft reperfusion and adequate analgesia. Balanced anesthesia is preferred because renal nociception is conducted multi-segmentally and chronically ill ESRD patients have labile psychological profile. Present study compared the efficacy ofdexmedetomidine with fentanyl administered via intravenous and epidural route before induction of general anesthesia.Prospective, double blind randomized study, recruited sixty hemo-dynamically stable ESRD adults, 18-55 years, scheduled for elective live related renal transplantation. Patients randomly received intravenous dexmedetomidine 0.5 渭g/kg followed by epidural dexmedetomidine 0.5 渭g/kg alongwith 5 ml; 0.25% ropivacaine or intravenous fentanyl 1 渭g/kg followed by epiduralfentanyl 1 渭g/kg alongwith 5 ml; 0.25% ropivacaine. All patients received standardized general anaesthesia and continuous epidural ropivacaine 0.25%; 4-8 ml/hr. Preoperative sedation, peri-operative haemodynamics, end tidal anaesthetic agent requirement, peri-operative fluid requirement, need for vasopressors, blood loss and early graft function was assessed.80% patients receiving intravenous dexmedetomidine did not require rescue midazolam for achieving satisfactory sedation before induction of general anaesthesia. Dexmedetomidine significantly reduced propofol and end tidal inhalational agents requirement and need for rescue analgesics. Early renal graft function (onset time of diuresis after declamping, 24 hours urine output and serum creatinine levels) was comparable. There were no adverse sequelae.Dexmedetomidine-based anaesthetic regimen versus fentanyl-based anaesthesia provided appropriate anxiolysis and analgesia for conducting invasive procedures and subsequent epidural administration of these agents reduced anaesthetic requirement and prolonged postoperative analgesia without compromising hemodynamics and respiratory parameters. Further dose finding studies can be conducted in kidney transplant recipients.
PMID:25668998      URL    
[本文引用:1]
[7] BENGGON M, CHEN H, APPLEGATE R, et al.Effect of dexmedetomidine on brain edema and neurological outcomes in surgicat brain injury in rats[J].Anesth Analg, 2012,115(1):154-159.
BACKGROUND: Surgical brain injury (SBI) is damage to functional brain tissue resulting from neurosurgical manipulations such as sharp dissection, electrocautery, retraction, and direct applied pressure. Brain edema is the major contributor to morbidity with inflammation, necrosis, oxidative stress, and apoptosis likely playing smaller roles. Effective therapies for SBI may improve neurological outcomes and postoperative morbidities associated with brain surgery. Previous studies show an adrenergic correlation to blood-brain barrier control. The alpha-2 receptor agonist dexmedetomidine (DEX) has been shown to improve neurological outcomes in stroke models. We hypothesized that DEX may reduce brain edema and improve neurological outcomes in a rat model of SBI.<br/>METHODS: Male Sprague-Dawley rats (n = 63) weighing 280 to 350 g were randomly assigned to 1 of 4 IP treatment groups: sham IP, vehicle IP, DEX 10 mg/kg, and DEX 30 mg/kg. Treatments were given 30 min before SBI. These treatment groups were repeated to observe the physiologic impact of DEX on mean arterial blood pressure (MAP), heart rate (HR), and blood glucose on SBI naive animals. Rats were also assigned to 4 postinjury IV treatment groups: sham IV, vehicle IV, DEX 10/5, and DEX 30/15 (DEX group doses were 10 and 30 mg/kg/hr, with 5 and 15 mg/kg initial loading doses, respectively). Initial loading doses began 20 min after SBI, followed by 2 h of infusion. SBI animals were subjected to neurological testing 24 h after brain injury by a blinded observer, promptly killed, and brain water content measured via the dry/wet weight method.<br/>RESULTS: All treatment groups showed a significant difference in ipsilateral frontal brain water content and neurological scores when compared with sham animals. However, there was no difference between DEX-treated and vehicle animals. Physiologic monitoring showed treatment with low or high doses of DEX significantly decreased MAP and HR, and briefly increased blood glucose compared with naive or vehicle-treated animals.<br/>CONCLUSIONS: DEX administration did not reduce brain edema or improve neurological function after SBI in this study. The statistical difference in brain water content and neurological scores when comparing sham treatment to vehicle and DEX treatments shows consistent reproduction of this model. Significant changes in MAP, HR, and blood glucose after DEX as compared to vehicle and sham treatments suggest appropriate delivery of drug. (Anesth Analg 2012;115:154-9)
DOI:10.1213/ANE.0b013e31824e2b86      Magsci    
[本文引用:1]
[8] 魏旭东, 朱容富. 右美托咪定在妇科腹腔镜全身麻醉手术苏醒期应用的效果及安全性[J]. 中国医药, 2014, 9(3):376-378.
目的 观察术中输注右美托咪定在妇科腹腔镜全身麻醉手术后苏醒期应用的效果及安全性.方法 将80例择期行妇科腹腔镜手术患者完全随机分成右美托咪定组和对照组,每组40例.停用麻醉药后,右美托咪定组经静脉泵注右美托咪定0.4 μg/kg,10 min泵完;对照组输注等量0.9%氯化钠注射液.观察麻醉诱导前、气管插管拔管时和气管插管拔管后不同时间点平均动脉压(MAP)和心率的变化﹔患者苏 醒时间、拔管时间以及拔管后10 min 视觉模拟评分(VAS)、警觉与镇静评分(OAA/S)、躁动发生率.结果与对照组比较,右美托咪定组拔管时及拔管后5 min、拔管后10 min的MAP明显降低,心率明显减慢[MAP:(89±14)mmHg(1 mmHg=0.133 kPa)比(107±15)mmHg,(75±13)mmHg比(98±16)mmHg,(78±17)mmHg比(95±15)mmHg;心率: (82±11)次/min比(113±13)次/min,(64±12)次/min比(97±11)次/min,(66±13)次/min比 (108±13)次/min](均P<0.05);右美托咪定组拔管后10 min VAS评分和OAA/S评分明显低于对照组[(2.6±0.6)分比(7.9±0.9)分,(3.9±0.5)分比(4.6±0.3)分] (P<0.05);右美托咪定组躁动发生率明显低于对照组[17.5%(7/14)比65.0%(26/40),P<0.05].结论 术中输注右美托咪定能预防妇科腹腔镜全身麻醉手术后苏醒期心血管反应,降低术后苏醒期躁动的发生率.
[本文引用:1]
[9] 周玉梅, 涂远艳, 李璟. 右美托咪定在气管内全身麻醉苏醒期拔管的应用[J].医学信息, 2010, 23(7):96-97.
目的:探讨右美托咪定用于气管 内全身麻醉苏醒期拔管的安全性及临床效果。方法:80例气管内全身麻醉行腹腔镜检查术的患者随机分成两组,安慰剂组(A组)和右美托咪定组(Y组),每组 40例。观察两组吸痰时、拔管时、拔管后5min时的心率、血压、呛咳反射及拔管时间。结果:两组患者给药前1min的心率、血压差异无统计学意义 (P0.05),两组吸痰时、拔管时的心率(HR)、血压(SAP、DAP)差异有统计学意义(P0.05),但Y组与给药前1min差异无统计学意义 (P0.05)。两组拔管后5min时的心率(HR)、血压(SAP、DAP)差异无统计学意义(P0.05),两组的拔管时间差异无统计学意义 (P0.05),两组的呛咳反射差异有统计学意义(P0.05)。结论:右美托咪定能减轻麻醉苏醒时气道、循环反射且不延长苏醒时间。
URL    
[本文引用:1]
[10] MIZUNO J, NAKATA Y, MORITA S, et al.Predisposing factors and prevention of emergence agitation[J].Masui, 2011, 60(4):425-435.
Agitation during the emergence from general anesthesia is a great post-operative problem that often injures the patients themselves and requires the medical staff to restrain and calm the patients. The predisposing factors for emergence agitation include anesthesia, operation, and patient. Sevoflurane anesthesia results in higher incidence of emergence agitation than halothane, because of the rapid emergence, and its effects on central nervous system inducing convulsion and post-operative behavioral changes. The otorhinolaryngologic and ophthalmologic surgeries, post-operative pain, young age, pre-operative anxiety, no past surgical history, and adjustment disorder of patients are risk factors for emergence agitation. The change from sevoflurane to propofol during anesthesia maintenance is a contributing factor to reduce incidence of emergence agitation. The medications including opioids, midazolam, alpha-2 agonists, ketamine, non-steroidal anti-inflammatory drugs, nitrous oxide, and propofol, and aggressive nerve block such as caudal epidural block for post-operative sedation and analgesia are effective to avoid incidence of emergence agitation. The calm emergence following general anesthesia would decrease the self-injuring behavior, and enhance the parent and caregiver satisfaction in general anesthesia and surgery.
PMID:21520589      URL    
[本文引用:1]
[11] MALVIYA S, VOEPEL-LEWIS T, RAMAMURTHI R J, et al.Clonidine for the prevention of emergence agitation in young children: efficacy and recoveryprofile[J]. Paediatr Anaesth, 2006,16(5):554-559.
Summary Background: Emergence agitation (EA) is a common postoperative problem in young children who have received sevoflurane and isoflurane for general anesthesia. This randomized, double-blinded study evaluated the efficacy of intraoperative clonidine in reducing EA, and describes its recovery profile. Methods: With Institutional Review Board approval and informed consent, children undergoing brief, minimally painful procedures were studied. All children received preemptive analgesia with acetaminophen and ketorolac, sevoflurane for induction, and isoflurane for maintenance of anesthesia. Children received either 2 mug.kg(-1) clonidine or placebo intravenously (i.v.) following induction of anesthesia. Children were observed postoperatively for behavior and side effects, and their parents were telephoned the next day to determine postdischarge recovery characteristics. Results: One hundred and twenty children were included in this study: 59 of whom received clonidine, and 61 placebo; 41% of those in the placebo group exhibited moderate-severe EA compared with only 22% of those in the clonidine group (P < 0.03). Compared with those who received placebo, children who received clonidine awakened more slowly (22 min vs 14 min), had a longer postanesthesia care unit stay (57 min vs 46 min), and experienced sleepiness more frequently after discharge (75% vs 39%; all comparisons significant at P < 0.03). There were no adverse cardiorespiratory events in either group. Conclusions: Findings demonstrate that i.v. clonidine administered after induction of anesthesia significantly reduces the incidence of EA in young children, but is associated with sleepiness postoperatively.
DOI:10.1111/j.1460-9592.2006.01818.x      PMID:16677266      URL    
[本文引用:1]
[12] 刘媛媛,万杏,刘敏,.盐酸右美托咪定对老年患者手术后早期认知功能的影响[J].医药导报,2015,34(2):214-217.
目的 探讨盐酸右美托咪定对老年患者手术后早期认知功能的影响及作用机制.方法 将88例老年手术患者随机分为两组.治疗组46例,麻醉诱导后静脉注射盐酸右美托咪定;对照组42例,麻醉诱导后注射等量0.9%氯化钠注射液.分别评价 两组简易智力状态检查表(MMSE)评分、术中与术后手术指标、术后认知功能障碍(POCD)发生率及脑氧代谢异常率.结果 两组患者手术情况差异无统计学意义(P>0.05).治疗组术后6h,1d的MMSE评分(22.28±3.62),(25.82±4.32)分,明显低 于术前(28.82±4.32)分(P<0.01),也显著低于同期对照组评分(P<0.01).治疗组术后6h,1 d POCD情况明显好于对照组,差异有统计学意义(P<0.01).但两组术后3d的POCD发生率均为0%.治疗组麻醉诱导后即刻(t0)、麻醉后60 min(t1)脑氧代谢异常(分别为19.57%,21.74%)明显低于对照组(t0:76.19%,t1:85.71%),差异有统计学意义 (P<0.01).但两组麻醉恢复时(t2)的脑氧代谢异常率比较差异无统计学意义(P>0.05).术中早期脑代谢异常和老年患者术后POCD密切相关 (OR=5.176,95% CI:3.961 ~ 18.006).治疗组术中低血压发生率(17.4%)和心动过缓发生率(10.9%)明显高于对照组的7.1%,2.4%(P<0.05).结论 盐酸右美托咪啶可预防老年患者术后POCD的发生,其作用机制主要与调节术中患者脑氧代谢功能有关.
DOI:10.3870/yydb.2015.02.021      URL    
[本文引用:1]
[13] VENN R M, HELL J, GROUNDS R M.Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care[J].Crit Care, 2000, 4(5):302-308.
[本文引用:1]
资源
PDF下载数    
RichHTML 浏览数    
摘要点击数    

分享
导出

相关文章:
关键词(key words)
右美托咪定,盐酸
手术,腹腔镜
结直肠癌根治术
苏醒质量


作者
叶刚
朱贤林
吴述轩
刘川鄂
覃斌